Defective CD19+CD24^hiCD38^hi transitional B-cell function in patients with relapsing-remitting MS

Abstract

CD19+CD24^hiCD38^hi transitional B cells physiologically represent the most potent regulatory B-cell subset and are functionally defective in patients with RRMS, an abnormality that may contribute to the immune pathological process.